<code id='D871C0941F'></code><style id='D871C0941F'></style>
    • <acronym id='D871C0941F'></acronym>
      <center id='D871C0941F'><center id='D871C0941F'><tfoot id='D871C0941F'></tfoot></center><abbr id='D871C0941F'><dir id='D871C0941F'><tfoot id='D871C0941F'></tfoot><noframes id='D871C0941F'>

    • <optgroup id='D871C0941F'><strike id='D871C0941F'><sup id='D871C0941F'></sup></strike><code id='D871C0941F'></code></optgroup>
        1. <b id='D871C0941F'><label id='D871C0941F'><select id='D871C0941F'><dt id='D871C0941F'><span id='D871C0941F'></span></dt></select></label></b><u id='D871C0941F'></u>
          <i id='D871C0941F'><strike id='D871C0941F'><tt id='D871C0941F'><pre id='D871C0941F'></pre></tt></strike></i>

          Home / comprehensive / leisure time

          leisure time


          leisure time

          author:leisure time    Page View:81134
          Franklin faces
          Adobe

          ARCH Venture Partners, one of the top investors in the biotech ecosystem, is raising $3 billion for a new fund.

          The Chicago-based firm filed paperwork with the Securities and Exchange Commission this week for what would be its 13th namesake fund. Arch estimated it would raise around $3 billion — roughly the same amount it raised during its more recent fundraising in 2022.

          advertisement

          Arch declined to comment on the new fundraising.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In